Osteoradionecrosis Scalp, Cranium Friday, October 16 Fri, Oct 16 1:00-2:30 p.m. CST
The panel will define the term osteoradionecrosis (ORN) of the skull and scalp and will outline its causes – whether it be the treatment of intracranial tumors or the result of radiation to tumors of the scalp. Reconstruction of the skull by various modalities will be presented as will the provision of soft tissue cover. The panelists will justify their reasons for when to stage or combine these procedures. The use of local and free flaps will be explored in different scenarios and advice will be given regarding the selection of recipient vessels in the head and neck. Finally, what to do when a construct becomes infected, when dead space needs to be filled and when hyperbaric oxygen needs to be used will be discussed by the panelists.
At the end of this activity participants will be able to:
- Diagnose ORN of the skull and scalp
- Grasp the importance of working with neurosurgeons in its excision;
- Appreciate that complete excision of affected bone and elimination of dead space are vital in the surgical treatment;
- Be able to enumerate the common constructs currently used in bony reconstruction of the skull;
- Understand that free flaps are often required for cover because radiation damage to the existing scalp makes local flaps difficult;
- Determine that vein grafts are often needed to access neck vessels;
- Realize that if the bony construct fails, 6-12 months should elapse before a second attempt is made.
Educational Grant Support Provided By: LEADERS: Allergan Aesthetics, an AbbVie Company; Galderma Laboratories, L.P.; Galatea Surgical, Inc.; INNOVATORS: Mentor Worldwide, LLC; SUPPORTERS: Johnson & Johnson Medical Devices Companies
In-Kind Support Provided By: Galatea Surgical, Inc.; Johnson & Johnson Medical Devices Companies
Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.
Designation: The ASPS designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.